ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates

ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.44 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.36 per share a year ago. These figures are adjusted for nonrecurring items. A quarter ago, it was expected that this company would post a loss of $0.45 per share when it actually produced a loss of$0.36, delivering a surprise of 20%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. scPharmaceuticals, which belongs to ...